glycine has been researched along with Hepatitis B, Chronic in 6 studies
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate the effect of decoction of turtle shell for anti-fibrosis combined with stronger neo-minophagen C on the indices of hepatic fibrosis in chronic hepatitis B." | 6.77 | [Effect of decoction of turtle shell for anti-fibrosis combined with stronger neo-minophagen C on indices of hepatic fibrosis in chronic hepatitis B]. ( Chang, Y; Zhang, L, 2012) |
"SNMC plus other therapy is more effective than other therapy alone in improving the hepatic function and hepatic fibrosis and increasing hepatic seroconversion rate in patients with chronic hepatitis B without causing serious adverse events." | 6.50 | [Efficacy and safety of Stronger Neo-Minophagen C for treatment of chronic hepatitis B: a meta-analysis of randomized controlled trials]. ( Chen, J; Huang, Y; Li, J; Qin, T; Wang, J, 2014) |
"To evaluate the effect of decoction of turtle shell for anti-fibrosis combined with stronger neo-minophagen C on the indices of hepatic fibrosis in chronic hepatitis B." | 2.77 | [Effect of decoction of turtle shell for anti-fibrosis combined with stronger neo-minophagen C on indices of hepatic fibrosis in chronic hepatitis B]. ( Chang, Y; Zhang, L, 2012) |
"SNMC plus other therapy is more effective than other therapy alone in improving the hepatic function and hepatic fibrosis and increasing hepatic seroconversion rate in patients with chronic hepatitis B without causing serious adverse events." | 2.50 | [Efficacy and safety of Stronger Neo-Minophagen C for treatment of chronic hepatitis B: a meta-analysis of randomized controlled trials]. ( Chen, J; Huang, Y; Li, J; Qin, T; Wang, J, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kusunoki, H | 1 |
Hamaguchi, I | 1 |
Kobayashi, N | 1 |
Nagata, T | 1 |
Chen, F | 1 |
Yao, Y | 1 |
Li, Z | 1 |
Deng, L | 1 |
He, R | 1 |
Chen, J | 1 |
Wang, J | 1 |
Qin, T | 1 |
Huang, Y | 1 |
Li, J | 1 |
Yang, L | 1 |
Yang, X | 1 |
Kong, X | 1 |
Cao, Z | 1 |
Zhang, Y | 1 |
Hu, Y | 1 |
Tang, K | 1 |
Sun, QF | 1 |
Ding, JG | 1 |
Wang, XF | 1 |
Fu, RQ | 1 |
Yang, JX | 1 |
Hong, L | 1 |
Xu, XJ | 1 |
Wang, JR | 1 |
Wu, JG | 1 |
Xu, DZ | 1 |
Zhang, L | 1 |
Chang, Y | 1 |
1 review available for glycine and Hepatitis B, Chronic
Article | Year |
---|---|
[Efficacy and safety of Stronger Neo-Minophagen C for treatment of chronic hepatitis B: a meta-analysis of randomized controlled trials].
Topics: Cysteine; Drug Combinations; Glycine; Glycyrrhetinic Acid; Hepatitis B e Antigens; Hepatitis B Surfa | 2014 |
3 trials available for glycine and Hepatitis B, Chronic
Article | Year |
---|---|
Covariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B.
Topics: Adolescent; Adult; Aged; Biomarkers; Case-Control Studies; Fatty Acids; Female; Gas Chromatography-M | 2016 |
Efficacy and safety of intravenous stronger neo-minophagen C and S-adenosyl-L-methionine in treatment of pregnant woman with chronic hepatitis B: a pilot study.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Cysteine; Demography; Dr | 2010 |
[Effect of decoction of turtle shell for anti-fibrosis combined with stronger neo-minophagen C on indices of hepatic fibrosis in chronic hepatitis B].
Topics: Adult; Aged; Alanine Transaminase; Animal Shells; Animals; Aspartate Aminotransferases; Cysteine; Dr | 2012 |
2 other studies available for glycine and Hepatitis B, Chronic
Article | Year |
---|---|
Chemical shift assignments of a fusion protein comprising the C-terminal-deleted hepatitis B virus X protein BH3-like motif peptide and Bcl-x
Topics: Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Hepatocellular; Dipeptides; Glycine; Hepati | 2022 |
Assessment of compensated advanced chronic liver disease based on serum bile acids in chronic hepatitis B patients.
Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Female; Glycine; Hepatitis B virus; Hepatitis B, Chro | 2023 |